NCT03591718View on ClinicalTrials.gov

A Study to Test Different Doses of BI 456906 in Patients With Obesity

PHASE1CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

July 26, 2018

Primary Completion Date

April 20, 2020

Study Completion Date

April 30, 2020

Conditions
Obesity
Interventions
DRUG

BI 456906

Solution for injection

DRUG

Placebo

solution for injection

Trial Locations (2)

41460

Profil Institut für Stoffwechselforschung GmbH, Neuss

55116

Profil Mainz GmbH & Co. KG, Mainz

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY